What it means to lose access to diabetes care By AMY BELL Only three pharma­ceutical corpora­tions – Eli Lilly, Novo Nordisk, and Sanofi – control 90 per cent of the entire insulin market. This means they can set prices as high as they wish, decide which insulin and delivery devices are on – and off…